UBS has given British American Tobacco (BAT) a "Neutral" rating and set a target price of 3000 Pence after reviewing a recent interim report.
Analyst Faham Baig believes that BAT's situation will improve in the coming year, although his forecast for the growth of BAT's operating profit (EBIT) in 2025 is lower than the consensus among analysts.
The report, published on December 11, 2024, highlights the potential for recovery within the company despite the cautious outlook reflected in the earnings estimates.
Investors will be closely monitoring BAT's performance as it navigates the changing market landscape.